Drug Class
antibody-drug conjugate
Type
brand
Active Ingredient
trastuzumab
📋Overview
Kadcyla is a medication that combines an antibody with a chemotherapy agent, designed to target specific cancer cells. It is most commonly associated with certain types of breast cancer that express the HER2 protein. By linking targeted therapy with chemotherapy, Kadcyla aims to deliver cancer-fighting agents directly to malignant cells. This approach is intended to minimize effects on healthy tissues while addressing aggressive forms of cancer.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Kadcyla
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.